Botanical

Cranberry

Vaccinium macrocarpon

Cranberry (Vaccinium macrocarpon) is best known as a urinary-health fruit, but this platform's corpus captures a different, less common use: two Brazilian randomized trials testing cranberry extract as an add-on therapy for rheumatoid arthritis, included in a larger meta-analysis of polyphenols for RA.

1

STUDY

11

STUDIED WITH

5

CONDITIONS

3

TRADITIONS

Studies about Cranberry in Akasha →

How it's used

Parts and preparations, and the conditions they're used for.

fruit · extractRheumatoid Arthritis · Inflammation · Chronic Pain

These uses are flagged for review — traditional-use claims kept as reported, never as advice.

What the studies found

Findings backed by a source paper, not traditional use alone.

fruit · extract — 2 RCTs from Brazil. Thimoteo 2019: DAS28 decreased at 12 weeks but CRP, ESR and RF unchanged. Fatel 2021: cranberry extract plus fish oil lowered ESR, CRP and DAS28 versus control and versus fish oil alone.

Read the source study →

Studies about Cranberry

1 completed study · newest first

Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials.

Zhiyong Long et al. (2023) · Frontiers in immunology

Whether the plant compounds often discussed for rheumatoid arthritis — turmeric, green tea, pomegranate, garlic — actually do anything is the question this meta-analysis set out to answer. This review gathered every randomized trial it could find on the question: 47 trials, nearly 3,900 people, fifteen different plant polyphenols, from Iran, China, Korea, Egypt, Japan, Brazil, India and the United States. The clearest picture came from two of them. The first is total glucosides of paeony, an extract of Chinese peony root that is a licensed prescription medicine in China. Twenty-three trials tested it — always added to standard RA drugs like methotrexate, never instead of them. Disease activity scores came down, and so did CRP, ESR and rheumatoid factor, the blood markers doctors track. The most interesting result: people taking it reported *fewer* side effects than people on the standard drugs alone. That fits how it is used clinically — it appears to soften the toll the conventional drugs take on the liver and stomach. The second is curcumin, the yellow compound in turmeric. Five trials, and the same direction: lower disease activity, lower inflammatory markers, no extra side effects. Green tea polyphenols looked promising across two trials. Saffron did not show a clear effect. Everything else — pomegranate, garlic, resveratrol, sesame, cinnamon, ginger, kudzu, cranberry, olive oil, quercetin — rests on one or two small trials apiece, which is encouraging but not yet evidence that bears weight. The honest caveat, which the authors state plainly themselves: the trials disagreed with each other a great deal, most were small, and when the researchers sliced the data by dose and duration some of the headline benefits faded. Nearly all of these were add-on studies. Nobody tested a polyphenol against methotrexate, so the evidence says nothing about replacing a prescribed medication. What it does support is turmeric and peony extract as the best-evidenced candidates, studied as additions to existing treatment rather than replacements for it.

Read summary →Full text available